(Press-News.org) BROOKLYN, N.Y.—Just months after setting a record for detecting the smallest single virus in solution, researchers at the Polytechnic Institute of New York University (NYU-Poly) have announced a new breakthrough: They used a nano-enhanced version of their patented microcavity biosensor to detect a single cancer marker protein, which is one-sixth the size of the smallest virus, and even smaller molecules below the mass of all known markers. This achievement shatters the previous record, setting a new benchmark for the most sensitive limit of detection, and may significantly advance early disease diagnostics. Unlike current technology, which attaches a fluorescent molecule, or label, to the antigen to allow it to be seen, the new process detects the antigen without an interfering label.
Stephen Arnold, university professor of applied physics and member of the Othmer-Jacobs Department of Chemical and Biomolecular Engineering, published details of the achievement in Nano Letters, a publication of the American Chemical Society.
In 2012, Arnold and his team were able to detect in solution the smallest known RNA virus, MS2, with a mass of 6 attograms. Now, with experimental work by postdoctoral fellow Venkata Dantham and former student David Keng, two proteins have been detected: a human cancer marker protein called Thyroglobulin, with a mass of just 1 attogram, and the bovine form of a common plasma protein, serum albumin, with a far smaller mass of 0.11 attogram. "An attogram is a millionth of a millionth of a millionth of a gram," said Arnold, "and we believe that our new limit of detection may be smaller than 0.01 attogram."
This latest milestone builds on a technique pioneered by Arnold and collaborators from NYU-Poly and Fordham University. In 2012, the researchers set the first sizing record by treating a novel biosensor with plasmonic gold nano-receptors, enhancing the electric field of the sensor and allowing even the smallest shifts in resonant frequency to be detected. Their plan was to design a medical diagnostic device capable of identifying a single virus particle in a point-of-care setting, without the use of special assay preparations.
At the time, the notion of detecting a single protein—phenomenally smaller than a virus—was set forth as the ultimate goal.
"Proteins run the body," explained Arnold. "When the immune system encounters virus, it pumps out huge quantities of antibody proteins, and all cancers generate protein markers. A test capable of detecting a single protein would be the most sensitive diagnostic test imaginable."
To the surprise of the researchers, examination of their nanoreceptor under a transmission electron microscope revealed that its gold shell surface was covered with random bumps roughly the size of a protein. Computer mapping and simulations created by Stephen Holler, once Arnold's student and now assistant professor of physics at Fordham University, showed that these irregularities generate their own highly reactive local sensitivity field extending out several nanometers, amplifying the capabilities of the sensor far beyond original predictions. "A virus is far too large to be aided in detection by this field," Arnold said. "Proteins are just a few nanometers across—exactly the right size to register in this space."
The implications of single protein detection are significant and may lay the foundation for improved medical therapeutics. Among other advances, Arnold and his colleagues posit that the ability to follow a signal in real time—to actually witness the detection of a single disease marker protein and track its movement—may yield new understanding of how proteins attach to antibodies.
Arnold named the novel method of label-free detection "whispering gallery-mode biosensing" because light waves in the system reminded him of the way that voices bounce around the whispering gallery under the dome of St. Paul's Cathedral in London. A laser sends light through a glass fiber to a detector. When a microsphere is placed against the fiber, certain wavelengths of light detour into the sphere and bounce around inside, creating a dip in the light that the detector receives. When a molecule like a cancer marker clings to a gold nanoshell attached to the microsphere, the microsphere's resonant frequency shifts by a measureable amount.
INFORMATION:
The research has been supported by a grant from the National Science Foundation (NSF). This summer, Arnold will begin the next stage of expanding the capacity for these biosensors. The NSF has awarded a new $200,000 grant to him in collaboration with University of Michigan professor Xudong Fan. The grant will support the construction of a multiplexed array of plasmonically enhanced resonators, which should allow a variety of protein to be identified in blood serum within minutes.
The publication in Nano Letters marks the 100th journal-paper published since the 1978 founding of NYU-Poly's Microparticle Photophysics Laboratory for BioPhotonics, directed by Arnold.
The Polytechnic Institute of New York University (formerly the Brooklyn Polytechnic Institute and the Polytechnic University, now widely known as NYU-Poly) is an affiliated institute of New York University, soon to be its School of Engineering. NYU-Poly, founded in 1854, is the nation's second-oldest private engineering school. It is presently a comprehensive school of education and research in engineering and applied sciences, rooted in a 159-year tradition of invention, innovation and entrepreneurship. It remains on the cutting edge of technology, innovatively extending the benefits of science, engineering, management and liberal studies to critical real-world opportunities and challenges, especially those linked to urban systems, health and wellness, and the global information economy. In addition to its programs on the main campus in New York City at MetroTech Center in downtown Brooklyn, it offers programs around the globe remotely through NYUe-Poly. NYU-Poly is closely connected to engineering in NYU Abu Dhabi and NYU Shanghai and to the NYU Center for Urban Science and Progress (CUSP) also at MetroTech, while operating two incubators in downtown Manhattan and Brooklyn. For more information, visit http://www.poly.edu.
NYU-Poly nano scientists reach holy grail in label-free cancer marker detection: Single molecules
2013-07-24
ELSE PRESS RELEASES FROM THIS DATE:
Improving medicine acceptance in kids: A matter of taste
2013-07-24
PHILADELPHIA (July 24, 2013) – Despite major advances in the pharmaceutical treatment of disease, many children reject medicines due to an aversion to bitter taste. As such, bitterness presents a key obstacle to the acceptance and effectiveness of beneficial drugs by children worldwide.
A new review, published online ahead of print in Clinical Therapeutics, addresses this critical problem by highlighting recent advances in the scientific understanding of bitter taste, with special attention to the sensory world of children.
Written by an interdisciplinary team of leading ...
Pre-clinical animal research must improve
2013-07-24
Less than five percent of promising basic science discoveries that claim clinical relevance lead to approved drugs within a decade, partly because of flawed pre-clinical animal research. A number of recent initiatives seek to improve the quality of such studies, and an article published this week in PLOS Medicine identifies key experimental procedures believed to increase clinical generalizability.
The authors, led by Jonathan Kimmelman of McGill University in Montréal, did a systematic literature search and identified 26 guidelines with 55 different procedures that groups ...
Barriers to interventions to prevent malaria in pregnancy similar across sub-Saharan Africa
2013-07-24
The main barriers to the access, delivery, and use of interventions that help to prevent malaria in pregnant women are relatively consistent across sub-Saharan African countries and may provide a helpful checklist to identify the factors influencing uptake of these important interventions, according to a study published in this week's PLOS Medicine.
The analysis by Jenny Hill and colleagues from the Liverpool School of Tropical Medicine in the UK, the London School of Hygiene & Tropical Medicine, and PATH in Seattle, USA, also found that there were more barriers to ...
Frontiers news briefs: July 23
2013-07-24
Frontiers in Pharmacology
Why are menthol cigarettes more addictive?
Smokers of menthol cigarettes crave cigarettes more frequently, find it more difficult to quit smoking, and are more likely to become addicted. The traditional explanation for the effect of menthol is that it masks the harsh taste of tobacco and thus entices people to smoke more.
But Nadine Kabbani from George Mason University in the USA here review recent scientific findings and proposes an novel explanation: menthol may directly promote nicotine craving because it binds to a particular type of ...
Difference in breast cancer survival between black and white women has not changed substantially
2013-07-24
In an analysis of 5-year survival rates among black and white women diagnosed with breast cancer between 1991 and 2005, black women continued to have a lower rate of survival, with most of the difference related to factors including poorer health of black patients at diagnosis and more advanced disease, rather than treatment differences, according to a study in the July 24/31 issue of JAMA.
"For 20 years health care investigators in the United States have been keenly aware of racial disparities in survival among women with breast cancer. Numerous reports have not only ...
Report documents organ transplantation as source of fatal rabies virus case
2013-07-24
An investigation into the source of a fatal case of raccoon rabies virus exposure indicates the individual received the virus via a kidney transplant 18 months earlier, findings suggesting that rabies transmitted by this route may have a long incubation period, and that although solid organ transplant transmission of infectious encephalitis is rare, further education to increase awareness is needed, according to a study in the July 24/31 issue of JAMA.
The rabies virus causes a fatal encephalitis (inflammation of the brain) and can be transmitted through tissue or organ ...
Survey assesses views of physicians regarding controlling health care costs
2013-07-24
In a survey of about 2,500 U. S. physicians on their perceived role in addressing health care costs, they reported having some responsibility to address health care costs in their practice and expressed general agreement with quality initiatives that may also reduce cost, but expressed less enthusiasm for cost containment involving changes in payment models, according to a study in the July 24/31 issue of JAMA.
"The increasing cost of U.S. health care strains the economy. Because physicians' decisions play a key role in overall health care spending and quality, several ...
Kidney stones associated with modest increased risk of coronary heart disease in women, but not men
2013-07-24
An analysis of data from three studies that involved a total of more than 240,000 participants found that a self-reported history of kidney stones was associated with a statistically significant increased risk of coronary heart disease among women but no significant association was evident for men, according to a study in the July 24/31 issue of JAMA.
"Nephrolithiasis [kidney stones] is a common condition, with the prevalence varying by age and sex. A recent estimate from the National Health and Nutrition Examination Survey, a representative sample of the U.S. population, ...
Increasing incidence of Type 1 diabetes among children in Finland appears to have leveled off
2013-07-24
"The incidence of type l diabetes (T1D), one of the most prevalent chronic diseases in children, has increased worldwide," write Valma Harjutsalo, Ph.D., of the Diabetes Prevention Unit, Helsinki, Finland, and colleagues, who conducted a study to examine the incidence rates of T1D between 2006 and 2011 in Finnish children younger than 15 years as well as the 32-year trend (1980-2011).
As reported in a Research Letter, all children with newly diagnosed T1D were ascertained using several nationwide registers. Age-standardized and age-specific annual incidence rates for ...
Genetic testing improved student learning in personalized medicine class, Stanford study finds
2013-07-24
STANFORD, Calif. — Students who had their genome tested as part of a groundbreaking medical school course on personalized medicine improved their knowledge of the class materials by an average of 31 percent compared with those who didn't undergo the testing, according to a study by researchers at the Stanford University School of Medicine.
While the sample size was small — 23 students sent their saliva to a commercial genetics testing company; eight did not — the results may encourage educators to consider this approach in the future, the authors said.
"These results ...